Advancing the Standards of Endocrine Care: AACE Scientific Conference Highlights Putting Science into Practice
Posted on: Monday, 11 April 2005, 09:00 CDT
News Advisory:
-- Advancing the Standards of Endocrine Care: AACE Scientific Conference Highlights Putting Science into Practice
-- Latest research on diabetes, obesity, thyroid and more to be presented
The clinical endocrinologist's role is more important than ever to many of the nation's most pressing health issues. Over 20 million Americans suffer from diabetes and an additional 41 million have pre-diabetes. Obesity is quickly becoming the leading cause of preventable death in the U.S. More than 27 million Americans are affected by thyroid disease and half are unaware they have the condition.
The American Association of Clinical Endocrinologists' (AACE) Fourteenth Annual Meeting and Clinical Congress, May 18 through May 22, at the Marriott Wardman Park Hotel in Washington, D.C., will highlight the latest research on these and other endocrine- related disorders.
MEETING TOPICS
-- The Women's Health Initiatives
-- Performance Enhancing Drugs
-- Pregnancy and Thyroid Disease
-- New Prevention Guidelines for Cardiovascular Disease in Women
---
DIABETES IN PREGNANCY
-- Hypertension and Diabetes
-- Current and Future Treatment of Obesity
-- Osteoporosis Management
-- Polycystic Ovary Syndrome
MEDIA EVENTS: State of Diabetes in America -- First-of-its- kind Report Evaluating America's Diabetes Health -- Wednesday, May 18, 10 a.m.
-- For the first time, AACE is releasing an in-depth, state- by- state evaluation of blood sugar control, which will provide a critical assessment of type 2 diabetes management across the United States.
-- Phone/Web access will be available.
Emerging Science: Exploring the Inner Dynamics of Diabetes -- Wednesday, May 18, 12 p.m.
-- Following the report highlighting the need for improved blood sugar control, AACE will host a lunchtime media "Teach In" designed to provide an in-depth review of the multi-dimensional pathophysiology of type 2 diabetes, current treatment approaches, and the next wave of emerging therapies.
-- Phone/Web access will be available.
Poster Session Press Preview -- Thursday, May 19, 9 a.m. to 9:45 a.m.
-- Over 140 posters addressing the latest research in the field will be available to view before opening to general meeting attendees.
NEW OPPORTUNITIES
Endocrinologia y Diabetologia en Espanol -- Saturday, May 21, 2 p.m. to 5 p.m.
-- For the first time, scientific sessions will be presented entirely in Spanish, including Diabetes in Latino and Hispanic Patients, The Role of Bariatric Surgery for Obesity, Hypothyroidism and Pregnancy: The Benefits of Early Treatment and Maternal-Fetal Health.
General meeting sessions in Spanish or Italian -- May 19-21
-- General sessions will be translated from English to Spanish or Italian to accommodate the AACE international membership base.
In addition to the above workshops, twenty-one Satellite Symposia covering related topics will be held throughout the meeting, including Wednesday afternoon, May 18.
------
AACE is a professional medical organization with more than 5,200 members in the United States and 84 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
For further information about AACE and the Annual Meeting, visit the AACE Web site at http://www.aace.com.
EDITOR'S NOTE: Registration is required for all media. Contact Sissy Horn or Sarah Bradley as listed above.
http://www.usnewswire.com
Source: U.S. Newswire
Related Articles
- InteKrin Therapeutics Presents Positive INT131 Phase 2b Results at the 45th Annual European Association for the Study of Diabetes Meeting
- Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
- GI Dynamics to Present Data From Clinical Weight Loss Study of EndoBarrier(TM) Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress
- Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients With Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
- Cytokinetics Announces Clinical Trials Data to Be Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology
- Clinical Data Shows Vitamin C May Reduce Risks of Cancer, Heart Disease and Variety of Other Health Disorders
- Walgreens Health Corner Clinics in Kansas City Ready Flu Shots for National Influenza Vaccination Week From Nov. 27 to Dec. 3
- Walgreens Health Corner Clinics in St. Louis Ready Flu Shots for National Influenza Vaccination Week From Nov. 27 to Dec. 3
- Diabetes Outcomes in the Indian Health System During the Era of the Special Diabetes Program for Indians and the Government Performance and Results Act
- New Eloxatin(R) and Taxotere(R) Research to Be Presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
User Comments (0)

RSS Feeds